Reports
Global Noninvasive Neuromodulation Market Share, Forecast: By Product: Repetitive Transcranial Magnetic Stimulation (rTMS), Transcutaneous Electrical Nerve Stimulation (TENS), Transcranial Direct Current Stimulation (tDCS), Others; By Application; By End Use; Regional Analysis; Competitive Landscape; 2024-2032
Global Noninvasive Neuromodulation Market Outlook
The global noninvasive neuromodulation market is being supported by the growth of global neuromodulation market, which reached a value of about USD 15.03 billion in 2023. The market is further expected to grow at a CAGR of 12% in the forecast period of 2024-2032 to reach a value of approximately USD 41.45 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Rising Popularity of TENS therapy to Boost the Noninvasive Neuromodulation Industry Growth
The noninvasive neuromodulation therapy TENS – Transcranial Electrical Nerve Stimulation has witnessed rising popularity over the years. This technique is used to treat a wide range of both acute and chronic pains from joints, muscles, spinal cord to tendons, and is forecast to boost market growth. The industry is bolstered by the rising demand for these units as they are small and portable and can therefore be used at home or anytime when pain relief is required. These are now being increasingly suggested by physical therapists, acupuncturists, and other healthcare professionals, thereby propelling the growth rate of the market over the forecast period.
Noninvasive Neuromodulation: Market Segmentation
Neuromodulation is defined as the alteration of nerve activity by targeting the stimulus, which could be electrical or chemical to specific neurological sites in the body. The main function of neuromodulation is in therapies; they can help restore function or relieve symptoms with neurological basis. Noninvasive is defined as not tending to destroy healthy tissue or physically enter the body. A lot of noninvasive neuromodulation techniques are used to treat spinal cord and transcranial stimulations.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on product, the market is divided into:
- Repetitive Transcranial Magnetic Stimulation (rTMS)
- Transcutaneous Electrical Nerve Stimulation (TENS)
- Transcranial Direct Current Stimulation (tDCS)
- Transcranial Alternating Current Stimulation (tACS)
- Transcutaneous Vagus Nerve Stimulation (tVNS)
- Transcutaneous Spinal Cord Stimulation (tSCS)
- Electroconvulsive Therapy (ECT)
- Others
On the basis of application, the market is segmented into:
- Pain Management
- Epilepsy
- Urinary and Fecal Incontinence
- Depression
- Migraine
- Spinal Cord Injury
- Others
By end use, the market is segregated into:
- Rehabilitation Centres
- Hospitals
- Speciality Clinics
- Others
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Increasing Demand for Transcutaneous Spinal Cord Stimulation to Boost the Industry
Continuous low voltage electric current is applied to the spinal cord and is known as transcutaneous spinal cord stimulation. This technique helps in numbing and reducing chronic pain and has witnessed massive growth in the market. The immediate benefit on body functions and pain relief is boosting this technique, thereby supporting the growth of the noninvasive neuromodulation industry during the forecast period. The ability to relieve pain and treat a lot of injuries is propelling the growth of this industry. North America is forecast to lead the market as they invest heavily into the research and implementation of these techniques.
Key Industry Players in the Global Noninvasive Neuromodulation Market
The report gives a detailed analysis of the following key players in the global noninvasive neuromodulation market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- GE Global Research
- Sooma Oy
- Soterix Medical Inc.
- electroCore Inc.
- Bioness Inc.
- Helius Medical Technologies Inc.
- Others
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2023 |
| Historical Period | 2018-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product, Application, End Use, Region |
| Breakup by Product | Repetitive Transcranial Magnetic Stimulation (rTMS), Transcutaneous Electrical Nerve Stimulation (TENS), Transcranial Direct Current Stimulation (tDCS), Transcranial Alternating Current Stimulation (tACS), Transcutaneous Vagus Nerve Stimulation (tVNS), Transcutaneous Spinal Cord Stimulation (tSCS), Electroconvulsive Therapy (ECT), Others |
| Breakup by Application | Pain Management, Epilepsy, Urinary and Fecal Incontinence, Depression, Migraine, Spinal Cord Injury, Others |
| Breakup by End-Use | Rehabilitation Centres, Hospitals, Speciality Clinics, Others |
| Breakup by Region | North America, Latin America, Europe, Middle East and Africa, Asia Pacific |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | GE Global Research, Sooma Oy, Soterix Medical Inc., electroCore Inc., Bioness Inc., Helius Medical Technologies Inc., Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Noninvasive Neuromodulation Market Analysis
8.1 Key Industry Highlights
8.2 Global Noninvasive Neuromodulation Historical Market (2018-2023)
8.3 Global Noninvasive Neuromodulation Market Forecast (2024-2032)
8.4 Global Noninvasive Neuromodulation Market by Product
8.4.1 Repetitive Transcranial Magnetic Stimulation (rTMS)
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2023)
8.4.1.3 Forecast Trend (2024-2032)
8.4.2 Transcutaneous Electrical Nerve Stimulation (TENS)
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2023)
8.4.2.3 Forecast Trend (2024-2032)
8.4.3 Transcranial Direct Current Stimulation (tDCS)
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2018-2023)
8.4.3.3 Forecast Trend (2024-2032)
8.4.4 Transcranial Alternating Current Stimulation (tACS)
8.4.4.1 Market Share
8.4.4.2 Historical Trend (2018-2023)
8.4.4.3 Forecast Trend (2024-2032)
8.4.5 Transcutaneous Vagus Nerve Stimulation (tVNS)
8.4.5.1 Market Share
8.4.5.2 Historical Trend (2018-2023)
8.4.5.3 Forecast Trend (2024-2032)
8.4.6 Transcutaneous Spinal Cord Stimulation (tSCS)
8.4.6.1 Market Share
8.4.6.2 Historical Trend (2018-2023)
8.4.6.3 Forecast Trend (2024-2032)
8.4.7 Electroconvulsive Therapy (ECT)
8.4.7.1 Market Share
8.4.7.2 Historical Trend (2018-2023)
8.4.7.3 Forecast Trend (2024-2032)
8.4.8 Others
8.5 Global Noninvasive Neuromodulation Market by Application
8.5.1 Pain Management
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2023)
8.5.1.3 Forecast Trend (2024-2032)
8.5.2 Epilepsy
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2023)
8.5.2.3 Forecast Trend (2024-2032)
8.5.3 Urinary and Fecal Incontinence
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2018-2023)
8.5.3.3 Forecast Trend (2024-2032)
8.5.4 Depression
8.5.4.1 Market Share
8.5.4.2 Historical Trend (2018-2023)
8.5.4.3 Forecast Trend (2024-2032)
8.5.5 Migraine
8.5.5.1 Market Share
8.5.5.2 Historical Trend (2018-2023)
8.5.5.3 Forecast Trend (2024-2032)
8.5.6 Spinal Cord Injury
8.5.6.1 Market Share
8.5.6.2 Historical Trend (2018-2023)
8.5.6.3 Forecast Trend (2024-2032)
8.5.7 Others
8.6 Global Noninvasive Neuromodulation Market by End Use
8.6.1 Rehabilitation Centres
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2018-2023)
8.6.1.3 Forecast Trend (2024-2032)
8.6.2 Hospitals
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2018-2023)
8.6.2.3 Forecast Trend (2024-2032)
8.6.3 Speciality Clinics
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2018-2023)
8.6.3.3 Forecast Trend (2024-2032)
8.6.4 Others
8.7 Global Noninvasive Neuromodulation Market by Region
8.7.1 Market Share
8.7.1.1 North America
8.7.1.2 Europe
8.7.1.3 Asia Pacific
8.7.1.4 Latin America
8.7.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2018-2023)
9.1.2 Forecast Trend (2024-2032)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2018-2023)
9.2.2 Forecast Trend (2024-2032)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2018-2023)
9.3.2 Forecast Trend (2024-2032)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2018-2023)
9.4.2 Forecast Trend (2024-2032)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2018-2023)
9.5.2 Forecast Trend (2024-2032)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 GE Global Research
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 Sooma Oy
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 Soterix Medical Inc.
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 electroCore, Inc
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 Bioness Inc.
12.2.5.1 Company Overview
12.2.5.2 Product Portfolio
12.2.5.3 Demographic Reach and Achievements
12.2.5.4 Certifications
12.2.6 Helius Medical Technologies, Inc.
12.2.6.1 Company Overview
12.2.6.2 Product Portfolio
12.2.6.3 Demographic Reach and Achievements
12.2.6.4 Certifications
12.2.7 Others
13 Industry Events and Developments
List of Key Figures and Tables
1. Global Noninvasive Neuromodulation Market: Key Industry Highlights, 2018 and 2032
2. Global Noninvasive Neuromodulation Historical Market: Breakup by Product (USD Billion), 2018-2023
3. Global Noninvasive Neuromodulation Market Forecast: Breakup by Product (USD Billion), 2024-2032
4. Global Noninvasive Neuromodulation Historical Market: Breakup by Application (USD Billion), 2018-2023
5. Global Noninvasive Neuromodulation Market Forecast: Breakup by Application (USD Billion), 2024-2032
6. Global Noninvasive Neuromodulation Historical Market: Breakup by End Use (USD Billion), 2018-2023
7. Global Noninvasive Neuromodulation Market Forecast: Breakup by End Use (USD Billion), 2024-2032
8. Global Noninvasive Neuromodulation Historical Market: Breakup by Region (USD Billion), 2018-2023
9. Global Noninvasive Neuromodulation Market Forecast: Breakup by Region (USD Billion), 2024-2032
10. North America Noninvasive Neuromodulation Historical Market: Breakup by Country (USD Billion), 2018-2023
11. North America Noninvasive Neuromodulation Market Forecast: Breakup by Country (USD Billion), 2024-2032
12. Europe Noninvasive Neuromodulation Historical Market: Breakup by Country (USD Billion), 2018-2023
13. Europe Noninvasive Neuromodulation Market Forecast: Breakup by Country (USD Billion), 2024-2032
14. Asia Pacific Noninvasive Neuromodulation Historical Market: Breakup by Country (USD Billion), 2018-2023
15. Asia Pacific Noninvasive Neuromodulation Market Forecast: Breakup by Country (USD Billion), 2024-2032
16. Latin America Noninvasive Neuromodulation Historical Market: Breakup by Country (USD Billion), 2018-2023
17. Latin America Noninvasive Neuromodulation Market Forecast: Breakup by Country (USD Billion), 2024-2032
18. Middle East and Africa Noninvasive Neuromodulation Historical Market: Breakup by Country (USD Billion), 2018-2023
19. Middle East and Africa Noninvasive Neuromodulation Market Forecast: Breakup by Country (USD Billion), 2024-2032
20. Global Noninvasive Neuromodulation Market Structure
Key Questions Answered in the Report
The global noninvasive neuromodulation market is being supported by the growing global neuromodulation market, which attained a value of nearly USD 15.03 billion in 2023.
The noninvasive neuromodulation industry is being aided by the growing global neuromodulation market, which is projected to grow at a CAGR of 12% between 2024 and 2032.
The major industry drivers include the rising investments in the healthcare sector, increased demand for transcutaneous spinal cord stimulation technique, growing popularity of noninvasive neuromodulation therapies to treat various acute and chronic pains in muscles and the spinal cord, and the rising incidences of neurological disorders, such as epilepsy, movement disorders, and others.
The key industry trend augmenting the market growth include the rising geriatric population worldwide.
The major regions in the industry are North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
The significant types of the product include repetitive transcranial magnetic stimulation (rTMS), transcutaneous electrical nerve stimulation (TENS), transcranial direct current stimulation (tDCS), transcranial alternating current stimulation (tACS), transcutaneous vagus nerve stimulation (tVNS), transcutaneous spinal cord stimulation (tSCS), electroconvulsive therapy (ECT), and others.
The major applications include pain management, epilepsy, urinary and fecal incontinence, depression, migraine, spinal cord injury, and others.
The significant end uses include rehabilitation centres, hospitals, speciality clinics, and others.
The major players in the industry are GE Global Research, Sooma Oy, Soterix Medical Inc., electroCore Inc, Bioness Inc., Helius Medical Technologies Inc., and others.
Analyst Review
The global noninvasive neuromodulation market is being supported by the growing global neuromodulation market, which attained a value of USD 15.03 billion in 2023. The market is driven by the growing popularity of noninvasive neuromodulation therapies to treat various acute and chronic pains. Aided by the growing geriatric population and the rising incidences of neurological ailments, the global neuromodulation market is expected to witness a further growth in the forecast period of 2024-2032, growing at a CAGR of 12%.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on product, the global noninvasive neuromodulation industry can be segmented into repetitive transcranial magnetic stimulation (rTMS), transcutaneous electrical nerve stimulation (TENS), transcranial direct current stimulation (tDCS), transcranial alternating current stimulation (tACS), transcutaneous vagus nerve stimulation (tVNS), transcutaneous spinal cord stimulation (tSCS), electroconvulsive therapy (ECT), and others. By application, the industry can be divided into pain management, epilepsy, urinary and fecal incontinence, depression, migraine, spinal cord injury, and others. On the basis of end use, the market can be categorised into rehabilitation centres, hospitals, speciality clinics, and others. The major regional markets for noninvasive neuromodulation are North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific. The key players in the above market include GE Global Research, Sooma Oy, Soterix Medical Inc., electroCore Inc, Bioness Inc., Helius Medical Technologies Inc., and others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$2799
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER